You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指午後跌幅曾擴至近350點 藥明生物挫近9%
港股兩連跌,今天跑輸區內,恆指在科指曾續挫2.8%至4,063主導,失守50天線(19,685),午後跌幅曾擴至343點,低見19,569,現報19,588,續跌324點或1.6%,但總成交額僅538億元。 藍籌股普遍下跌,尤其是藥明生物(02269.HK)兩連跌兼失守50天線(46.4元),午後跌幅擴大,最低見42.3元,現報42.6元,續挫8.8%;但石藥(01093.HK)逆升1.4%報7.14元。 人匯再創逾半年低,中金指內房本月首三周推盤量較5月降兩成,四大藍籌內房及兩大物管股均跌逾2%-6%,龍湖(00960.HK)、碧桂園02007.HK)及旗下碧服(06098.HK)沽壓最大,分別報19.38元、1.66元及9.96元。 海底撈(06862.HK)吐逾5.4%曾低見17.76元;美團(03690.HK)續吐近4%報131.6元。 聯想(00992.HK)、中芯(00981.HK)及聯通(00762.HK)跌逾3%-4%。 阿里巴巴(09988.HK)公布,張勇將於9月10日起退任公司主席及首席執行官職務,其職位將分別由集團執行副主席蔡崇信及淘天集團董事長吳泳銘接替。阿里午後股價變動不大,報88.25元,續吐1.6%。 然而,據報獲麥格理洽購澳洲附屬最多五成股權的中電(00006.HK)升破250天線(59.7元),最高見61元,現報60.75元,逆升6%。 恆地(00012.HK)、九倉置業(01997.HK)、百度(09888.HK)、康師傅(00322.HK)升逾2%-2%,後者跑贏報12.2元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account